Answers are grounded in this paper and cite their sources.
The last 20 years have witnessed remarkable improvements in the prognosis of children with many forms of malignant disease. The reasons for these improvements relate not only to the development of better drugs and more effective radiotherapy, but also to the multidisciplinary approach involving surgeon, chemotherapist, radiotherapist and immunotherapist in providing optimum treatment for the child with a particular cancer. In this paper, the changing role of the pediatric oncologist, surgeon and radiotherapist in improving the management of pediatric cancer is discussed.
No takes yet. Share an insight, caveat, or question.
Hammond et al. (1978) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: